Descripciones mejoradas de Syndetics:

Presents practical information for the diagnosis, management, and referral of common ocular disorders. Includes updated images and resources, additional sample clinical problems, and the latest information on such areas as glaucoma care and eye-related aging changes.

Tabla de contenidos provista por Syndetics

• Figures(p. ix)
• Preface(p. xi)
• Who's Who in Eye Care(p. xiii)
• Test Your Knowledge(p. xiv)
• Chapter 1 The Eye Examination(p. 1)
• Objectives(p. 1)
• Relevance(p. 1)
• Basic Information(p. 2)
• The Patient's History(p. 2)
• Anatomy(p. 3)
• Anatomic Aging Changes(p. 6)
• Optics(p. 8)
• Visual Acuity(p. 8)
• When To Examine(p. 9)
• Additional Tests(p. 9)
• How to Examine(p. 9)
• Distance Visual Acuity Testing(p. 10)
• Near Visual Acuity Testing(p. 12)
• Visual Acuity Estimation in an Uncooperative Patient(p. 12)
• Confrontation Field Testing(p. 13)
• Amsler Grid Testing(p. 14)
• External Inspection(p. 14)
• Upper Lid Eversion(p. 15)
• Ocular Motility Testing(p. 15)
• Pupillary Reaction Testing(p. 15)
• Anterior Chamber Depth Assessment(p. 16)
• Intraocular Pressure Measurement(p. 17)
• Color Vision Testing(p. 19)
• Fluorescein Staining of Cornea(p. 19)
• Ophthalmoscopy(p. 19)
• Summary of Steps in Eye Examination(p. 24)
• Management or Referral(p. 25)
• Reduced Visual Acuity(p. 25)
• Abnormal Fundus Appearance(p. 25)
• Shallow Anterior Chamber Depth/Elevated Intraocular Pressure(p. 26)
• Points to Remember(p. 26)
• Sample Problems(p. 26)
• Annotated Resources(p. 28)
• Chapter 2 Acute Visual Loss(p. 31)
• Objectives(p. 31)
• Relevance(p. 31)
• Basic Information(p. 31)
• How to Examine(p. 32)
• Visual Acuity Testing(p. 32)
• Confrontation Field Testing(p. 32)
• Pupillary Reactions(p. 32)
• Ophthalmoscopy(p. 32)
• Penlight Examination(p. 33)
• Tonometry(p. 33)
• How to Interpret the Findings(p. 33)
• Media Opacities(p. 33)
• Corneal Edema(p. 33)
• Hyphema(p. 33)
• Cataract(p. 34)
• Vitreous Hemorrhage(p. 34)
• Retinal Disease(p. 35)
• Optic Nerve Disease(p. 39)
• Visual Pathway Disorders(p. 42)
• Functional Disorders(p. 43)
• Acute Discovery of Chronic Visual Loss(p. 43)
• Points to Remember(p. 43)
• Sample Problems(p. 44)
• Annotated Resources(p. 46)
• Chapter 3 Chronic Visual Loss(p. 49)
• Objectives(p. 49)
• Chronic Visual Loss in the Geriatric Population(p. 49)
• Glaucoma(p. 50)
• Relevance(p. 50)
• Basic Information(p. 52)
• Intraocular Pressure(p. 52)
• Types of Glaucoma(p. 53)
• Optic Nerve(p. 53)
• Relationship of Iop and Optic Nerve(p. 54)
• When to Examine(p. 54)
• How to Examine(p. 54)
• How to Interpret the Findings(p. 55)
• Management or Referral(p. 57)
• Cataract(p. 57)
• Relevance(p. 57)
• Basic Information(p. 58)
• Lens(p. 59)
• Cataract(p. 59)
• Symptoms of Cataract(p. 59)
• When to Examine(p. 60)
• How to Examine(p. 61)
• How to Interpret the Findings(p. 62)
• Management or Referral(p. 62)
• Macular Degeneration(p. 63)
• Relevance(p. 63)
• Basic Information(p. 63)
• Macular Anatomy(p. 63)
• Age-Related Macular Changes(p. 64)
• When to Examine(p. 67)
• How to Examine(p. 67)
• How to Interpret the Findings(p. 68)
• Management or Referral(p. 68)
• The Visually Impaired Patient(p. 69)
• Points to Remember(p. 70)
• Sample Problems(p. 71)
• Annotated Resources(p. 72)
• Chapter 4 The Red Eye(p. 75)
• Objectives(p. 75)
• Relevance(p. 75)
• Basic Information(p. 75)
• Disorders Associated with a Red Eye(p. 76)
• History(p. 79)
• How to Examine(p. 80)
• How to Interpret the Findings(p. 82)
• Symptoms of Red Eye(p. 83)
• Signs of Red Eye(p. 85)
• Associated Systemic Problems(p. 87)
• Laboratory Diagnosis(p. 87)
• Management or Referral(p. 88)
• Blepharitis(p. 88)
• Stye and Chalazion(p. 90)
• Subconjunctival Hemorrhage(p. 91)
• Conjunctivitis(p. 91)
• Therapeutic Warnings(p. 92)
• Topical Anesthetics(p. 92)
• Topical Corticosteroids(p. 92)
• Points to Remember(p. 92)
• Sample Problems(p. 93)
• Annotated Resources(p. 97)
• Chapter 5 Ocular and Orbital Injuries(p. 99)
• Objectives(p. 99)
• Relevance(p. 99)
• Basic Information(p. 100)
• Anatomy and Function(p. 100)
• When to Examine(p. 103)
• How to Examine(p. 103)
• History(p. 104)
• Visual Acuity Testing(p. 104)
• External Examination(p. 105)
• Pupillary Reactions(p. 107)
• Ocular Motility Testing(p. 107)
• Ophthalmoscopy(p. 107)
• Radiologic Studies(p. 107)
• Management or Referral(p. 108)
• True Emergency(p. 108)
• Urgent Situation(p. 108)
• Semiurgent Condition(p. 110)
• Treatment Skills(p. 111)
• Ocular Irrigation(p. 111)
• Foreign-Body Removal(p. 112)
• Prescribing Eye Medication(p. 112)
• Patching(p. 112)
• Suturing(p. 113)
• Points to Remember(p. 113)
• Sample Problems(p. 114)
• Annotated Resources(p. 118)
• Chapter 6 Amblyopia and Strabismus(p. 121)
• Objectives(p. 121)
• Relevance(p. 121)
• Basic Information(p. 122)
• Amblyopia(p. 122)
• Strabismus(p. 124)
• How to Examine and Interpret the Findings(p. 126)
• Amblyopia Testing(p. 127)
• Strabismus Testing(p. 129)
• Other Tests(p. 133)
• Management or Referral(p. 134)
• Amblyopia(p. 134)
• Strabismus(p. 135)
• Points to Remember(p. 136)
• Sample Problems(p. 136)
• Annotated Resources(p. 140)
• Chapter 7 Neuro-Ophthalmology(p. 141)
• Objectives(p. 141)
• Relevance(p. 141)
• How to Examine(p. 142)
• Visual Acuity Testing(p. 142)
• Visual Field Testing(p. 142)
• Pupillary Reactions(p. 143)
• Ocular Motility Testing(p. 144)
• Ophthalmoscopy(p. 145)
• How to Interpret the Findings(p. 146)
• Pupillary Disorders(p. 146)
• Other Cranial Nerve Palsies(p. 150)
• Optic Nerve Disease(p. 153)
• Visual Field Defects(p. 156)
• Visual Hallucinations(p. 157)
• Cognitive Visual Loss: The Visual Variant of Alzheimer's Disease(p. 159)
• Points to Remember(p. 159)
• Sample Problems(p. 160)
• Annotated Resources(p. 164)
• Chapter 8 Ocular Manifestations of Systemic Disease(p. 165)
• Objectives(p. 165)
• Relevance(p. 165)
• Diabetes Mellitus(p. 166)
• Hypertension(p. 170)
• Arteriolar Sclerosis(p. 170)
• Elevated Blood Pressure(p. 172)
• Diagnostic Concerns(p. 172)
• Management(p. 172)
• Pregnancy(p. 173)
• Sickle Cell Anemia(p. 174)
• Thyroid Disease(p. 174)
• Sarcoidosis and Other Inflammatory and Autoimmune Conditions(p. 175)
• Malignancy(p. 176)
• Acquired Immunodeficiency Syndrome(p. 177)
• Syphilis(p. 179)
• Other Systemic Infections(p. 179)
• Points to Remember(p. 180)
• Sample Problems(p. 181)
• Annotated Resources(p. 182)
• Chapter 9 Drugs and the Eye(p. 185)
• Objectives(p. 185)
• Relevance(p. 185)
• Basic Information(p. 187)
• Topical Ocular Diagnostic Drugs(p. 188)
• Fluorescein Dye(p. 188)
• Anesthetics(p. 188)
• Mydriatics(p. 189)
• Topical Ocular Therapeutic Drugs(p. 190)
• Decongestants(p. 190)
• Agents for Relief of Allergic Conjunctivitis(p. 191)
• Anti-Inflammatory Agents(p. 191)
• Agents for the Relief of Dry Eye Symptoms(p. 191)
• Antibiotics(p. 191)
• Antiviral Agents(p. 192)
• Systemic Side Effects of Glaucoma Medications(p. 192)
• Beta-Adrenergic Blockers(p. 192)
• Cholinergic-Stimulating Drugs(p. 193)
• Alpha-2 Adrenoreceptor Agonists(p. 194)
• Adrenergic-Stimulating Drugs(p. 194)
• Prostaglandin Analogues(p. 195)
• Carbonic Anhydrase Inhibitors(p. 195)
• Ocular Side Effects of Systemic Drugs(p. 195)
• Amiodarone(p. 195)
• Biphosphonates(p. 196)
• Chloroquines(p. 196)
• Chlorpromazine(p. 197)
• Corticosteroids(p. 197)
• Digitalis(p. 197)
• Diphenylhydantoin(p. 197)
• Ethambutol(p. 197)
• Hmg-Coa Reductase Inhibitors (Statins)(p. 198)
• Rifabutin (Mycobutin)(p. 198)
• Sildenafil (Viagra) and Tadalifil (Cialis)(p. 198)
• Thioridazine(p. 198)
• Topiramate (Topimax)(p. 198)
• Points to Remember(p. 199)
• Sample Problems(p. 199)
• Annotated Resources(p. 202)
• Index(p. 203)